Biomarkers of Endometrial Receptivity

Recruiting N/A Interventional Study
IVF Infertility Treatment Fertility Disorders Embryo Transfer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 36
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
476 (estimated)
Sponsor
The Institute of Molecular and Translational Medicine, Czech Republic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Analysis of proteins from cervical mucus will be done in patients undergoing infertility treatment (fresh or frozen embryo transfer). Cervical mucus will be analysed for potential new biomarkers of endometrium receptivity. Comparison of the peptide spectrum will be done for the pregnant and not pregnant patients.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria - Arm A - stimulated cycle: * female aged less than 37 years (maximally 36y + 364d) * no smoker * normal menstrual cycles lasting between 25 to 35 days * had been infertile for less than five years * normal responder * fewer than three failed cycles of assisted reproduction treat…
Contacts

Radovan Pilka, Prof.MD.PhD.

+420739329868

radovan.pilka@fnol.cz

CONTACT

Petr Dzubak, MD.PhD.

+420604851158

dzubakp@gmail.com

CONTACT